Am J Perinatol 2016; 33(11): 1072-1075
DOI: 10.1055/s-0036-1586108
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry: Nursing Aspects

Lisa A. Hom
1   Children's National Heart Institute, Children's National Health System, Washington, District of Columbia
,
Gerard R. Martin
1   Children's National Heart Institute, Children's National Health System, Washington, District of Columbia
› Author Affiliations
Further Information

Publication History

Publication Date:
07 September 2016 (online)

Abstract

Congenital heart disease (CCHD) is the most common birth defect. Screening for the most critical forms (CCHD) using pulse oximetry was added to the Recommended Uniform Screening Panel in the United States in 2011. Since then, CCHD screening has become nearly universal in the United States. Nurses are ideally situated to contribute to the development of best practices for implementation and provide education to families on CCHD screening. Much of the standardization, advocacy, and development of national recommendations occurred with key input from nurses. Nurses often have responsibility for educating parents, performing the screening, interpreting the screening algorithm, and the documentation of results. The nurse role often includes implementing follow-up quality improvement initiatives to ensure that systematic and accurate screening occurs. Smooth implementation can be achieved by identifying champions early, obtaining input from a multidisciplinary team including both physician and nursing leaders, and identifying ways to integrate screening into already existing workflow. By knowing the basics of why screening is important, how to screen, current recommendations on the follow-up for positive screens and the limitations of CCHD screening, nurses can advocate for their patients and positively impact outcomes for infants born with CCHD through early identification before discharge.

 
  • References

  • 1 Mahle WT, Martin GR, Beekman III RH, Morrow WR. ; Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012; 129 (01) 190-192
  • 2 Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 2008; 162 (10) 969-974
  • 3 de-Wahl Granelli A, Wennergren M, Sandberg K. , et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009; 338: a3037
  • 4 Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379 (9835): 2459-2464
  • 5 Hokanson JS. Pulse oximetry screening for unrecognized congenital heart disease in neonates. Neonatology Today 2010; 5 (12) 1-6
  • 6 O'Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007; 92: F465-F467
  • 7 Riede FT, Wörner C, Dähnert I, Möckel A, Kostelka M, Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine—results from a prospective multicenter study. Eur J Pediatr 2010; 169 (08) 975-981
  • 8 Singh A, Rasiah SV, Ewer AK. The impact of routine predischarge pulse oximetry screening in a regional neonatal unit. Arch Dis Child Fetal Neonatal Ed 2014; 99 (04) F297-F302
  • 9 Bradshaw EA, Cuzzi S, Kiernan SC, Nagel N, Becker JA, Martin GR. Feasibility of implementing pulse oximetry screening for congenital heart disease in a community hospital. J Perinatol 2012; 32 (09) 710-715
  • 10 Children's National Medical Center. Congenital Heart Disease Screening Program Toolkit: A Toolkit for Implementing Screening. Washington, DC: Children's National Medical Center; 2014. Available at http://childrensnational.org/healthcare-providers/tools-for-your-practice/pulse-ox-congenital-heart-disease-screening/pulseox-toolkit-materials . Accessed July 7, 2016
  • 11 Kemper AR, Mahle WT, Martin GR. , et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128 (05) e1259-e1267
  • 12 Martin GR, Beekman III RH, Mikula EB. , et al. Implementing recommended screening for critical congenital heart disease. Pediatrics 2013; 132 (01) e185-e192
  • 13 Peterson C, Grosse SD, Oster ME, Olney RS, Cassell CH. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Pediatrics 2013; 132 (03) e595-e603
  • 14 Narayen IC, Blom NA, Ewer AK, Vento M, Manzoni P, te Pas AB. Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why?. Arch Dis Child Fetal Neonatal Ed 2016; 101 (02) F162-F167
  • 15 Oster ME, Kuo KW, Mahle WT. Quality improvement in screening for critical congenital heart disease. J Pediatr 2014; 164 (01) 67-71.e2